CRM1 Is a Cellular Target of Curcumin: New Insights for the Myriad of Biological Effects of an Ancient Spice
Authors:
Abstract
Curcumin is the major constituent of turmeric plant, an ancient spice widely used in Indian cuisine and traditional herbal medicine. Recently, the potential medical use of curcumin as anti‐cancer and anti‐inflammatory agent has set off an upsurge in research into the mechanism for its broad biological effects. We showed that CRM1, an important nuclear exportin, is a cellular target of curcumin by serious experimental and theoretical investigation. Using a nuclear export functional assay, we observed a clear and rapid shift of cargo proteins from a cytoplasmic localization to the nucleus when treated with curcumin or its structural analogue dibenzylideneacetone (DBA). We demonstrated that curcumin could specifically target the conserved Cys528 of CRM1 through mass spectrometric analysis and in vivo experiments. Furthermore, computational modeling has revealed that curcumin could be correctly docked into the hydrophobic pocket of CRM1 judged from shape complementarity and putative molecular interactions. The Michael acceptor moiety on curcumin is within the appropriate distance to enable Michael reaction with Cys residue of CRM1. More importantly, we showed that nuclear retention of FOXO1 could be observed in the presence of Leptomycin B (LMB) or curcumin whereas in cells expressing the CRM1‐Cys528 mutant, only a cytoplasmic localization was observed. The inhibition of nuclear traffic by curcumin may account for its myriad of biological effects, particularly for its therapeutic properties in cancer and inflammatory diseases. Our findings may have important implications for further clinical investigation of curcumin.Keywords
This publication has 48 references indexed in Scilit:
- Structural basis for cooperativity of CRM1 export complex formationProceedings of the National Academy of Sciences, 2012
- NESdb: a database of NES-containing CRM1 cargoesMolecular Biology of the Cell, 2012
- Antileukemic activity of nuclear export inhibitors that spare normal hematopoietic cellsLeukemia, 2012
- RETRACTED: Suppression of pro-inflammatory and proliferative pathways by diferuloylmethane (curcumin) and its analogues dibenzoylmethane, dibenzoylpropane, and dibenzylideneacetone: Role of Michael acceptors and Michael donorsBiochemical Pharmacology, 2011
- Alkylation of Cysteine 468 in Stat3 Defines a Novel Site for Therapeutic DevelopmentACS Chemical Biology, 2011
- The Anti-inflammatory Prostaglandin 15-Deoxy-Δ12,14-PGJ2 Inhibits CRM1-dependent Nuclear Protein ExportJournal of Biological Chemistry, 2010
- Targeting breast stem cells with the cancer preventive compounds curcumin and piperineBreast Cancer Research and Treatment, 2009
- Structural basis for assembly and disassembly of the CRM1 nuclear export complexNature Structural & Molecular Biology, 2009
- Structural basis for leucine-rich nuclear export signal recognition by CRM1Nature, 2009
- GROMACS: Fast, flexible, and freeJournal of Computational Chemistry, 2005